Gene Pharmaceutical And Biotech India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.13 M
- Company Age 31 Year, 11 Months
- Last Filing with ROC 31 Mar 2006
- Open Charges ₹ 5.50 Cr
About Gene Pharmaceutical And Biotech India
Gene Pharmaceutical And Biotech India Private Limited (GPABIPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 1993 and has a history of 31 years and 11 months. Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2006. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.13 M.
The company currently has active open charges totaling ₹5.50 Cr.
Komal Mohan and Ramabadran Chandramouli serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U17111TZ1993PTC004271
-
Company No.
004271
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 1993
-
Date of AGM
26 Sep 2006
-
Date of Balance Sheet
31 Mar 2006
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Gene Pharmaceutical And Biotech India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Komal Mohan
|
Director | 10-Feb-2005 | Current |
|
Ramabadran Chandramouli
|
Additional Director | 04-Jul-2007 | Current |
Financial Performance of Gene Pharmaceutical And Biotech India.
Enhance accessibility to Gene Pharmaceutical And Biotech India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gene Pharmaceutical And Biotech India?
Unlock access to Gene Pharmaceutical And Biotech India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹5.50 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 5.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jun 2006 | State Bank Of India | ₹5.50 Cr | Open |
How Many Employees Work at Gene Pharmaceutical And Biotech India?
Unlock and access historical data on people associated with Gene Pharmaceutical And Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gene Pharmaceutical And Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gene Pharmaceutical And Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
